Hinge Health (HNGE) 10K Form and Latest SEC Filings 2026

Hinge Health logo
$115.08 -6.21 (-5.12%)
As of 02:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Hinge Health SEC Filings & Recent Activity

Hinge Health (NYSE:HNGE) has submitted 223+ documents to the U.S. Securities and Exchange Commission (SEC) since 2019. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Hinge Health's financial statements. The most recent filing was a Form 4 submitted on November 13, 2026.

Form 4
Hinge Health, Inc. Reports Ownership Change on Nov. 13, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
Hinge Health Files Quarterly Report on Nov. 9, 2026

The 10-Q contains Hinge Health's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Hinge Health SEC Filing History

Browse Hinge Health's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

Filing Date
0 Results
DateFilerForm TypeView
11/13/2026 5:15 AM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2026 5:28 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2026 5:30 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2026 6:56 AM
Hinge Health (1673743) Subject
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/10/2026 3:27 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/09/2026 3:30 PM
Hinge Health (1673743) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2026 4:52 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2026 4:53 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2026 5:44 PM
Hinge Health (1673743) Subject
Insight Venture Partners X (0) Co-Investors
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/14/2026 5:18 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Delaware
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/14/2026 4:55 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/14/2026 4:28 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Cayman
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/13/2026 4:27 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2026 4:28 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2026 7:20 AM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/13/2026 7:20 AM
Hinge Health (1673743) Subject
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2026 8:57 PM
Hinge Health (1673743) Issuer
Perez Daniel Antonio (2063236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2026 3:31 PM
Hinge Health (1673743) Subject
Perez Daniel Antonio (2063236) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/06/2026 3:04 PM
Hinge Health (1673743) Issuer
Sloat Tyler (1735436) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2026 5:47 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2026 5:49 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2026 6:04 PM
Hinge Health (1673743) Subject
Insight Venture Partners X (0) Co-Investors
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2026 5:48 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Delaware
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2026 5:31 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2026 5:13 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Cayman
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2026 4:07 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2026 3:28 PM
Hinge Health (1673743) Subject
Pursley James (1783108) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2026 4:47 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2026 6:21 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2026 3:15 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2026 6:38 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2026 6:35 PM
Hinge Health (1673743) Issuer
Perez Daniel Antonio (2063236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2026 5:50 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2026 3:30 PM
Hinge Health (1673743) Subject
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2026 3:44 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2026 4:57 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2026 4:58 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2026 4:50 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2026 5:14 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2026 3:08 PM
Hinge Health (1673743) Subject
Michael Triplett 2012 Irrevocable Trust. (1980707) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2026 4:12 PM
Hinge Health (1673743) Subject
JL 2025 Family Trust LLC (2152243) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Your father's savings lost half their value after 1971. (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
09/01/2026 4:08 PM
Hinge Health (1673743) Subject
Jeffrey Lieberman 2012 Family Trust (2029414) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2026 4:03 PM
Hinge Health (1673743) Subject
Lieberman Jeffrey (1328837) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2026 5:06 PM
Hinge Health (1673743) Subject
Triplett Thomas Michael (1897385) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2026 4:15 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2026 4:17 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2026 4:18 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/24/2026 4:31 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 4:32 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 5:47 PM
Hinge Health (1673743) Issuer
Leslie Kristina M (1307207) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 4:19 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2026 3:26 PM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2026 5:22 PM
Hinge Health (1673743) Subject
Leslie Kristina M (1307207) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2026 3:33 PM
Bessemer Venture Partners X L.P. (1768640) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2026 3:34 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2026 5:53 PM
Hinge Health (1673743) Subject
Insight Holdings Group, LLC (1305473) Filed by
Form SCHEDULE 13G/A
08/14/2026 3:15 PM
Bessemer Venture Partners X L.P. (1768640) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G/A
08/12/2026 8:11 PM
Hinge Health (1673743) Issuer
Wardi Teddie Benjamin (1869541) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2026 3:39 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 5:46 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 5:48 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2026 8:06 PM
Hinge Health (1673743) Issuer
Perez Daniel Antonio (2063236) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2026 8:07 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2026 8:17 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2026 6:46 PM
Hinge Health (1673743) Issuer
Sloat Tyler (1735436) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2026 4:48 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144/A
07/07/2026 3:37 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Delaware
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2026 3:46 PM
Hinge Health (1673743) Subject
Insight Venture Partners X (0) Co-Investors
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2026 3:27 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2026 3:14 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Cayman
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2026 3:35 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 3:51 PM
Hinge Health (1673743) Subject
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 8:25 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 8:27 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2026 4:24 PM
Hinge Health (1673743) Subject
Insight Venture Partners X (0) Co-Investors
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 4:20 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Delaware
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 3:55 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2026 3:47 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Cayman
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2026 8:56 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2026 8:57 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2026 3:52 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2026 8:52 PM
Hinge Health (1673743) Issuer
Insight Holdings Group, LLC (1305473) Reporting
Insight Venture Associates X, L.P. (1844845) Reporting
Insight Venture Associates X, Ltd. (1803240) Reporting
Insight Venture Partners (0) Cayman
Insight Venture Partners X, L.P. (1710959) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2026 4:38 PM
Hinge Health (1673743) Subject
Insight Venture Partners X, L.P. (1710959) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2026 4:24 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Cayman
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2026 4:29 PM
Hinge Health (1673743) Subject
Insight Venture Partners (0) Delaware
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2026 4:18 PM
Hinge Health (1673743) Subject
Insight Venture Partners X (0) Co-Investors
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2026 3:18 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2026 3:06 PM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2026 3:02 PM
Atomico Advisors IV, Ltd. (2069654) Filed by
Hinge Health (1673743) Subject
Form SCHEDULE 13G/A
06/05/2026 7:16 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 5:51 PM
Hinge Health (1673743) Issuer
Leslie Kristina M (1307207) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
Earn $4,500 a month? Your income may count for more (Ad)

Earn $4,500 or more a month? Pennie lets you explore personal loan options that consider your income, not just your credit score. Options include personal loans up to $250,000 and APRs starting at 5.99%. Checking your rate is free, and the soft credit check won't affect your score. Pennie is a loan marketplace, not a lender. Offers come from third-party partners and are not guaranteed.tc pixel

Check your personal loan rate with Pennie in about two minutes with no fee
06/04/2026 3:19 PM
Hinge Health (1673743) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2026 4:31 PM
Hinge Health (1673743) Issuer
Robinson Elliott (2058536) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 6:10 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 6:13 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 3:15 PM
Bessemer Venture Partners X Institutional L.P. (1748910) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2026 6:08 PM
Hinge Health (1673743) Issuer
Mecklenburg Gabriel M.I. (2062781) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2026 6:14 PM
Hinge Health (1673743) Issuer
Pursley James (1783108) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2026 6:16 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 3:45 PM
Budge James (1338176) Reporting
Hinge Health (1673743) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Hinge Health SEC Filings - Frequently Asked Questions

Hinge Health (HNGE) has submitted 223+ filings to the SEC since 2019. You can browse the complete history or filter by form type using the tools above.

Hinge Health's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Hinge Health's financial statements page.

The most recent filing was a Form 4 submitted on November 13, 2026. This was an insider ownership change filed by 4 - Hinge Health, Inc. (0001673743) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NYSE:HNGE are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 11/13/2026. New filings are added as they're published.
From Our Partners